Yunnan Bethany Biotechnology Group

Yunnan Bethany Biotechnology Group is one of the...

• CSI 300.

Yunnan Bethany Biotechnology Group is a company listed under the stock ticker 300957 (CN).

View the org chart displaying its 2 main executives

Most searched biographies at Yunnan Bethany Biotechnology Group

• Zhen Yu Guo, General Manager and Chairman of the Board
• Long Wang, Chief Financial Officer & Secretary

Create your alert
to follow the executive moves at Yunnan Bethany Biotechnology Group.

Yunnan Bethany Biotechnology Group has 2,279 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Yunnan Bethany Biotechnology Group

Social media about Yunnan Bethany Biotechnology Group

• Yunnan Bethany Biotechnology Group on Wikipedia, Google News & Yahoo Finance
• Yunnan Bethany Biotechnology Group on LinkedIn, Twitter & YouTube

Call Yunnan Bethany Biotechnology Group at +86 400...

View the org chart

Register to receive your alert

Report an error